Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-12

Clinical Trial Update: Dysport Dose-Ranging Treatment of Platysmal Bands [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on dose-ranging Dysport treatment for platysmal bands across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Clinical Testing of Beverly Hills | Conditions: Platysma Bands | Phase 1, Phase 2 | Status: UNKNOWN